The anti-cancer drug trametinib suppresses angiotensin-induced cardiac remodelling in mice but is detrimental to function
Cooper STE., Duvenage E., Gattari D., Cull JJ., Dash PR., Chan D., Soria ML., Rossi M., Nasuto SJ., Holderbaum W., Kelion AD., Sugden PH., Glennon PE., Clerk A.